|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Gustin DM and Brenner DE: Chemoprevention
of colon cancer:current status and future prospects. Cancer
Metastasis Rev. 21:323–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lin JM, Chen YQ, Wei LH, Chen XZ, Xu W,
Hong ZF, Sferra TJ and Peng J: Hedyotis Diffusa Willd
extract induces apoptosis via activation of the
mitochondrion-dependent pathway in human colon carcinoma cells. Int
J Oncol. 37:1331–1338. 2010.
|
|
4.
|
Van Cutsem E and Costa F: Progress in the
adjuvant treatment of colon cancer: has it influenced clinical
practice? JAMA. 294:2758–2760. 2005.PubMed/NCBI
|
|
5.
|
Longley DB, Allen WL and Johnston PG: Drug
resistance, predictive markers and pharmacogenomics in colorectal
cancer. Biochim Biophys Acta. 1766:184–196. 2006.PubMed/NCBI
|
|
6.
|
Lippman SM: The dilemma and promise of
cancer chemoprevention. Nat Clin Pract Oncol. 10:5232006.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Folkman J: Anti-angiogenesis: new concept
for therapy of solid tumors. Ann Surg. 75:409–416. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Holash J, Wiegand SJ and Yancopoulos GD:
New model of tumor angiogenesis: dynamic balance between vessel
regression and growth mediated by angiopoietins and VEGF. Oncogene.
18:5356–5362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Folkman J: Seminars in Medicine of the
Beth Israel Hospital, Boston. Clinical applications of research on
angiogenesis. N Engl J Med. 333:1757–1763. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Folkman J: Angiogenesis: an organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar
|
|
12.
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cook KM and Figg WD: Angiogenesis
inhibitors: current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ingham PW, Nakano Y and Seger C:
Mechanisms and functions of Hedgehog signalling across the metazoa.
Nat Rev Genet. 12:393–406. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Theunissen JW and de Sauvage FJ: Paracrine
Hedgehog signaling in cancer. Cancer Res. 69:6007–6010. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Das S, Tucker JA, Khullar S, Samant RS and
Shevde LA: Hedgehog signaling in tumor cells facilitates
osteoblast-enhanced osteolytic metastases. PLoS One. 7:e343742012.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sahebjam S, Siu LL and Razak AA: The
utility of hedgehog signaling pathway inhibition for cancer.
Oncologist. 17:1090–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yoshikawa K, Shimada M, Miyamoto H,
Higashijima J, Miyatani T, Nishioka M, Kurita N, Iwata T and Uehara
H: Sonic hedgehog relates to colorectal carcinogenesis. J
Gastroenterol. 44:1113–1117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Varnat F, Duquet A, Malerba M, Zbinden M,
Mas C, Gervaz P and Ruiz i Altaba A: Human colon cancer epithelial
cells harbour active HEDGEHOG-GLI signalling that is essential for
tumour growth, recurrence, metastasis and stem cell survival and
expansion. EMBO Mol Med. 1:338–351. 2009. View Article : Google Scholar
|
|
20.
|
Mazumdar T, DeVecchio J, Shi T, Jones J,
Agyeman A and Houghton JA: Hedgehog signaling drives cellular
survival in human colon carcinoma cells. Cancer Res. 71:1092–1102.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lum L and Beachy PA: The Hedgehog response
network: sensors, switches, and routers. Science. 304:1755–1759.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Varjosalo M and Taipale J: Hedgehog:
functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lin JM, Wei LH, Shen AL, Cai QY, Xu W, Li
H, Zhan YZ, Hong ZF and Peng J: Hedyotis diffusa Willd
extract suppresses Sonic hedgehog signaling leading to the
inhibition of colorectal cancer angiogenesis. Int J Oncol.
42:651–656. 2013. View Article : Google Scholar
|
|
24.
|
Auzenne EJ, Klostergaard J, Mandal PK,
Liao WS, Lu Z, Gao F, Bast RC Jr, Robertson FM and McMurray JS: A
phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3
inhibits tumor growth and angiogenesis. J Exp Ther Oncol.
10:155–162. 2012.PubMed/NCBI
|
|
25.
|
Bromberg J and Wang TC: Inflammation and
cancer: IL-6 and STAT3 complete the link. Cancer Cell. 15:79–80.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kusaba T, Nakayama T, Yamazumi K, Yakata
Y, Yoshizaki A, Inoue K, Nagayasu T and Sekine I: Activation of
STAT3 is a marker of poor prognosis in human colorectal cancer.
Oncol Rep. 15:1445–1451. 2006.PubMed/NCBI
|
|
27.
|
Franke TF, Kaplan DR, Cantley LC and Toker
A: Direct regulation of the Akt proto-oncogene product by
phosphatidylinositol-3, 4-bisphosphate. Science. 275:665–668. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Clarke RB: p27KIP1
phosphorylation by PKB/Akt leads to poor breast cancer prognosis.
Breast Cancer Res. 5:162–163. 2003. View
Article : Google Scholar
|
|
29.
|
Chang F, Lee JT, Navolanic PM, Steelman
LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA:
Involvement of PI3K/Akt pathway in cell cycle progression,
apoptosis, and neoplastic transformation: a target for cancer
chemotherapy. Leukemia. 17:590–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Sun D, Liu Y, Yu Q, Zhou Y, Zhang R, Chen
X, Hong A and Liu J: The effects of luminescent ruthenium(II)
polypyridyl functionalized selenium nanoparticles on bFGF-induced
angiogenesis and AKT/ERK signaling. Biomaterials. 34:171–180. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Al-Ansari MM, Hendrayani SF, Tulbah A,
Al-Tweigeri T, Shehata AI and Aboussekhra A: p16INK4A
represses breast stromal fibroblasts migration/invasion and their
VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
Neoplasia. 14:1269–1277. 2012.
|
|
32.
|
Pratheeshkumar P, Budhraja A, Son YO, Wang
X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, Chen G, Luo J
and Shi X: Quercetin inhibits angiogenesis mediated human prostate
tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K
signaling pathways. PLoS One. 7:e475162012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Li W, Tan D, Zhang Z, Liang JJ and Brown
RE: Activation of Akt-mTOR-p70S6K pathway in angiogenesis in
hepatocellular carcinoma. Oncol Rep. 20:713–719. 2008.PubMed/NCBI
|
|
34.
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. EMBO Rep. 10:194–200. 2009.PubMed/NCBI
|
|
36.
|
Lin JM, Wei LH, Xu W, Hong ZF, Liu XX and
Peng J: Effect of Hedyotis Diffusa Willd extract on tumor
angiogenesis. Mol Med Rep. 4:1283–1288. 2011.PubMed/NCBI
|
|
37.
|
Peng J, Chen YQ, Lin JM, Zhuang QC, Xu W,
Hong ZF and Sferra TJ: Patrinia Scabiosaefolia extract
suppresses proliferation and promotes apoptosis by inhibiting STAT3
pathway in human multiple myeloma cells. Mol Med Rep. 4:313–318.
2011.
|
|
38.
|
Wei LH, Chen YQ, Lin JM, Zhao JY, Chen XZ,
Xu W, Liu XX, Sferra TJ and Peng J: Scutellaria Barbata D.
Don induces apoptosis of human colon carcinoma cell via activation
of the mitochondrion-dependent pathway. J Med Plants Res.
5:1962–1970. 2011.
|
|
39.
|
Zheng LP, Chen YQ, Lin W, Zhuang QC, Chen
XZ, Xu W, Liu XX, Peng J and Sferra TJ: Spica Prunellae
extract promotes mitochondrion-dependent apoptosis in a human colon
carcinoma cell line. Afr J Pharm Pharmacol. 5:327–335. 2011.
View Article : Google Scholar
|
|
40.
|
Ikeda Y, Murakami A and Ohigashi H:
Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr
Food Res. 52:26–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Andersson D, Liu JJ, Nilsson A and Duan
RD: Ursolic acid inhibits proliferation and stimulates apoptosis in
HT29 cells following activation of alkaline sphingomyelinase.
Anticancer Res. 23:3317–3322. 2003.PubMed/NCBI
|
|
42.
|
Prasad S, Yadav VR, Sung B, Reuter S,
Kannappan R, Deorukhkar A, Diagaradjane P, Wei C,
Baladandayuthapani V, Krishnan S, Guha S and Aggarwal BB: Ursolic
acid inhibits growth and metastasis of human colorectal cancer in
an orthotopic nude mouse model by targeting multiple cell signaling
pathways: chemosensitization with capecitabine. Clin Cancer Res.
18:4942–4953. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Pola R, Ling LE, Silver M, Corbley MJ,
Kearney M, Pepinsky RB, Shapiro R, Taylor FR, Baker DP and Asahara
T: The morphogen Sonic hedgehog is an indirect angiogenic agent
upregulating two families of angiogenic growth factors. Nat Med.
7:706–711. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Kujawski M, Kortylewski M, Lee H, Herrmann
A, Kay H and Yu H: Stat3 mediates myeloid cell-dependent tumor
angiogenesis in mice. J Clin Invest. 118:3367–3677. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Muñoz-Chápuli R, Quesada AR and Angel
Medina M: Angiogenesis and signal transduction in endothelial
cells. Cell Mol Life Sci. 61:2224–2243. 2004.
|
|
46.
|
Chen HX and Cleck JN: Adverse effects of
anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol.
6:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Zangari M, Fink LM, Elice F, Zhan F,
Adcock DM and Tricot GJ: Thrombotic events in patients with cancer
receiving antiangiogenesis agents. J Clin Oncol. 27:4865–4873.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Higa GM and Abraham J: Biological
mechanisms of bevacizumab-associated adverse events. Expert Rev
Anticancer Ther. 9:999–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Eikesdal HP and Kalluri R: Drug resistance
associated with antiangiogenesis therapy. Semin Cancer Biol.
19:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Rak J and Kerbel RS: bFGF and tumor
angiogenesis - Back in the limelight? Nat Med. 3:1083–1084. 1997.
View Article : Google Scholar : PubMed/NCBI
|
